These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 28213771)
21. Discovery of 1H-indole-2-carboxamides as novel inhibitors of the androgen receptor binding function 3 (BF3). Ban F; Leblanc E; Li H; Munuganti RS; Frewin K; Rennie PS; Cherkasov A J Med Chem; 2014 Aug; 57(15):6867-72. PubMed ID: 25025737 [TBL] [Abstract][Full Text] [Related]
22. Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces. Kim J; Kim H; Park SB J Am Chem Soc; 2014 Oct; 136(42):14629-38. PubMed ID: 25310802 [TBL] [Abstract][Full Text] [Related]
23. Identification of Novel Human Breast Carcinoma (MDA-MB-231) Cell Growth Modulators from a Carbohydrate-Based Diversity Oriented Synthesis Library. Lenci E; Innocenti R; Biagioni A; Menchi G; Bianchini F; Trabocchi A Molecules; 2016 Oct; 21(10):. PubMed ID: 27775632 [TBL] [Abstract][Full Text] [Related]
24. Concise syntheses of 7-anilino-indoline-N-benzenesulfonamides as antimitotic and vascular disrupting agents. Mehndiratta S; Chiang YF; Lai MJ; Lee HY; Chen MC; Kuo CC; Chang CY; Chang JY; Liou JP Bioorg Med Chem; 2014 Sep; 22(17):4917-23. PubMed ID: 25059503 [TBL] [Abstract][Full Text] [Related]
25. Improving both aqueous solubility and anti-cancer activity by assessing progressive lead optimization libraries. Liu Y; Li F; Wu L; Wang W; Zhu H; Zhang Q; Zhou H; Yan B Bioorg Med Chem Lett; 2015 May; 25(9):1971-5. PubMed ID: 25827524 [TBL] [Abstract][Full Text] [Related]
26. Integrating virtual screening and biochemical experimental approach to identify potential anti-cancer agents from drug databank. Deka SJ; Roy A; Manna D; Trivedi V J Bioinform Comput Biol; 2018 Jun; 16(3):1850002. PubMed ID: 29566637 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of spiro[cyclopropane-1,3'-indolin]-2'-ones as potential anticancer agents. Reddy CN; Nayak VL; Mani GS; Kapure JS; Adiyala PR; Maurya RA; Kamal A Bioorg Med Chem Lett; 2015 Oct; 25(20):4580-6. PubMed ID: 26330077 [TBL] [Abstract][Full Text] [Related]
28. Design, synthesis of phenstatin/isocombretastatin-oxindole conjugates as antimitotic agents. Kumar GB; Nayak VL; Sayeed IB; Reddy VS; Shaik AB; Mahesh R; Baig MF; Shareef MA; Ravikumar A; Kamal A Bioorg Med Chem; 2016 Apr; 24(8):1729-40. PubMed ID: 26970659 [TBL] [Abstract][Full Text] [Related]
29. Structure-based design of HSPA5 inhibitors: from peptide to small molecule inhibitors. Huang M; Li Z; Li D; Walker S; Greenan C; Kennedy R Bioorg Med Chem Lett; 2013 May; 23(10):3044-50. PubMed ID: 23562057 [TBL] [Abstract][Full Text] [Related]
30. Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery. Lu PH; Kung FL; Kuo SC; Chueh SC; Guh JH Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):223-33. PubMed ID: 17102938 [TBL] [Abstract][Full Text] [Related]
32. Discovery of Small Molecules for Repressing Cap-Independent Translation of Human Vascular Endothelial Growth Factor (hVEGF) as Novel Antitumor Agents. Wang SK; Wu Y; Wang XQ; Kuang GT; Zhang Q; Lin SL; Liu HY; Tan JH; Huang ZS; Ou TM J Med Chem; 2017 Jul; 60(13):5306-5319. PubMed ID: 28530833 [TBL] [Abstract][Full Text] [Related]
33. Design and optimization of hybrid of 2,4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents. Zhou W; Huang A; Zhang Y; Lin Q; Guo W; You Z; Yi Z; Liu M; Chen Y Eur J Med Chem; 2015; 96():269-80. PubMed ID: 25899332 [TBL] [Abstract][Full Text] [Related]
34. Small-molecule intramimics of formin autoinhibition: a new strategy to target the cytoskeletal remodeling machinery in cancer cells. Lash LL; Wallar BJ; Turner JD; Vroegop SM; Kilkuskie RE; Kitchen-Goosen SM; Xu HE; Alberts AS Cancer Res; 2013 Nov; 73(22):6793-803. PubMed ID: 24242070 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine. White AW; Carpenter N; Lottin JR; McClelland RA; Nicholson RI Eur J Med Chem; 2012 Oct; 56():246-53. PubMed ID: 22995819 [TBL] [Abstract][Full Text] [Related]
36. Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction. Wang L; Li L; Zhou ZH; Jiang ZY; You QD; Xu XL Eur J Med Chem; 2017 Aug; 136():63-73. PubMed ID: 28482218 [TBL] [Abstract][Full Text] [Related]
37. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence. Disney MD; Angelbello AJ Acc Chem Res; 2016 Dec; 49(12):2698-2704. PubMed ID: 27993012 [TBL] [Abstract][Full Text] [Related]
38. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies. Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558 [TBL] [Abstract][Full Text] [Related]
39. Dual targeting of tumour cells and host endothelial cells by novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines. Nathwani SM; Butler S; Meegan MJ; Campiani G; Lawler M; Williams DC; Zisterer DM Cancer Chemother Pharmacol; 2010 Jan; 65(2):289-300. PubMed ID: 19479253 [TBL] [Abstract][Full Text] [Related]
40. Synthesis of substituted benzimidazolyl curcumin mimics and their anticancer activity. Woo HB; Eom YW; Park KS; Ham J; Ahn CM; Lee S Bioorg Med Chem Lett; 2012 Jan; 22(2):933-6. PubMed ID: 22222040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]